ESR1 and breast cancer: The impact of hormone receptors (ER and PR) has been extensively studied in breast cancer and in different gynecological tumors, observing an association between their higher expression and better prognosis.12,36,37 In the present study, we detected, through univariate analysis, an association between lower expression of PR and a higher risk of relapse.